PhD: Gene Therapy for Leukodystrophies (Preclinical)

Amsterdam UMC

Amsterdam

On-site

EUR 39,000 - 49,000

Full time

14 days+
Application generator

Stand out for this role — generate a tailored resume and cover letter in about a minute.

Get past ATS filters

Benefits offered by this job

Living allowance
Mobility allowance
Family allowance
Pension ABP
Transport reimbursement
Bicycle scheme
GoodHabitz access
Staff association and events

Job summary

Amsterdam UMC, in an international, interdisciplinary setting, invites applications for a doctoral candidate to contribute to preclinical development of gene therapy for leukodystrophies. You will work on AAV efficacy in mouse models, apply genome-editing, and analyse results to align preclinical readouts with clinical outcomes.

You will collaborate across POLARIS partner organisations, benefit from doctoral training, and develop transferable skills within a vibrant research environment.

Qualifications

  • Master’s degree in life sciences or related discipline.
  • Fluency in English, written and spoken.
  • Formal FELASA or equivalent animal-work qualification preferred.
  • Interest in translational neuroscience and rare disease research.

Responsibilities

  • Test efficacy and safety of AAV gene therapy in mouse models.
  • Apply genome-editing approaches to assess therapeutic efficacy.
  • Use molecular techniques and in vivo mouse models to study disease mechanisms.
  • Analyze results and align preclinical readouts with clinical outcomes.
  • Collaborate with Amsterdam UMC and POLARIS partners; participate in trainings.

Skills

Molecular techniques
Viral vectors
Data analysis
Communication
Team collaboration

Education

Master's degree
Life sciences
Molecular sciences

Tools

FELASA certification

Job description

Amsterdam UMC, in an international, interdisciplinary setting, invites applications for a doctoral candidate to contribute to preclinical development of gene therapy for leukodystrophies. You will work on AAV efficacy in mouse models, apply genome-editing, and analyse results to align preclinical readouts with clinical outcomes.

You will collaborate across POLARIS partner organisations, benefit from doctoral training, and develop transferable skills within a vibrant research environment.

Get your free, confidential resume review.
or drag and drop your file here.
Similar jobs

Similar jobs worth comparing

PhD: Gene Therapy for Leukodystrophies (AAV & Genome Editing)
PhD: Gene Therapy for Leukodystrophies (AAV & Genome Editing)

SIGRA • Amsterdam

On-site
EUR 39,000 - 49,000
PhD in LNP Gene Therapy for Translational Neuroscience
PhD in LNP Gene Therapy for Translational Neuroscience

Amsterdam UMC • Netherlands

On-site
EUR 21,000 - 30,000
MSCA-DN PhD position in gene therapy for leukodystrophies (Amsterdam, NL)
MSCA-DN PhD position in gene therapy for leukodystrophies (Amsterdam, NL)

SIGRA • Amsterdam

On-site
EUR 39,000 - 49,000
PhD in LNP Gene Therapy for Leukodystrophies
PhD in LNP Gene Therapy for Leukodystrophies

SIGRA • Amsterdam

On-site
EUR 30,000 - 42,000
Salary and mobility allowance
Network-wide training and secondments
International collaboration
PhD in Therapeutic Genome Editing for Leukodystrophies
PhD in Therapeutic Genome Editing for Leukodystrophies

SIGRA • Amsterdam

On-site
EUR 32,000 - 42,000
PhD in Translational In Vivo Neuroscience: Leukodystrophy & EEG
PhD in Translational In Vivo Neuroscience: Leukodystrophy & EEG

Amsterdam UMC • Netherlands

On-site
EUR 23,000 - 33,000
PhD in Translational In Vivo Neuroscience for Leukodystrophy
PhD in Translational In Vivo Neuroscience for Leukodystrophy

SIGRA • Amsterdam

On-site
EUR 35,000 - 42,000
MSCA-DN PhD position in gene therapy for leukodystrophies (Amsterdam, NL)
MSCA-DN PhD position in gene therapy for leukodystrophies (Amsterdam, NL)

Amsterdam UMC • Amsterdam

On-site
EUR 39,000 - 49,000
Living allowance
Mobility allowance
Family allowance
+5
MSCA-DN PhD in lipid nanoparticle gene therapy for leukodystrophies (London, UK)
MSCA-DN PhD in lipid nanoparticle gene therapy for leukodystrophies (London, UK)

SIGRA • Amsterdam

On-site
EUR 30,000 - 42,000
Salary and mobility allowance
Network-wide training and secondments
International collaboration
MSCA-DN PhD in lipid nanoparticle gene therapy for leukodystrophies (London, UK)
MSCA-DN PhD in lipid nanoparticle gene therapy for leukodystrophies (London, UK)

Amsterdam UMC • Netherlands

On-site
EUR 21,000 - 30,000